Literature DB >> 24897173

Preventing infective complications following leech therapy: elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana using antibiotic feeding.

Agata Litwinowicz1, Joanna Blaszkowska.   

Abstract

BACKGROUND: Hirudotherapy is often used successfully in modern medicine, especially in plastic and reconstructive surgery. However, Aeromonas infections are the most common complications of post-operative leech application. Hence, prophylactic antibiotic administration is recommended before and during leech therapy. It has been confirmed that patient safety and achieving the desired therapeutic effect depend mainly on the microbiologic purity of the animals used. The aims of this study were to find a safe and practical way to eradicate symbiotic Aeromonas spp. occuring in the intestine of Hirudo verbana.
METHODS: Leeches were fed artificially with 1.5 mL of sterile defibrinated sheep blood supplemented with ciprofloxacin (CIP) or cefotaxime (CTX), at bacteriostatic concentrations of 0.2 mcg/mL or 1.5 mcg/mL, and bactericidal concentrations of 20 mcg/mL or 50 mcg/mL, respectively. Bacteria were isolated from the leech intestines before and after feeding at different time intervals: 1, 7, 14, 21, and 28 d.
RESULTS: Biochemical identification of bacterial isolates from water samples and intestines of H. verbana using the API-NE20 test showed that A. veronii biovar sobria was predominant. Bacteria belonging to the genus Aeromonas were detected in all control leeches. The results showed that optimum eradication of bacteria from leech intestines was obtained using 20 mcg/mL of CIP and 50 mcg/mL of CTX, which decreased the number of Aeromonas spp. to undetectable levels for two weeks after feeding in all treated leeches. A statistically significant reduction in the number of bacterial colonies (p<0.0001) was observed in leeches treated with bacteriostatic concentrations of CIP or CTX; no bacterial growth was found on the plates after only seven days of feeding with antibiotics. All water samples in which the leeches were kept before treatment were contaminated with Aeromonas spp., whereas these samples were negative after antibiotic feeding of animals.
CONCLUSIONS: All leeches were ready to take a blood meal after treatment, suggesting the possibility of using ciprofloxacin-treated or cefotaxime-treated leeches instead of chemoprophylaxis in patients undergoing hirudotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24897173      PMCID: PMC4268569          DOI: 10.1089/sur.2014.036

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  26 in total

Review 1.  Leeches and their microbiota: naturally simple symbiosis models.

Authors:  Joerg Graf; Yoshitomo Kikuchi; Rita V M Rio
Journal:  Trends Microbiol       Date:  2006-07-14       Impact factor: 17.079

2.  Infection risk related to the use of medicinal leeches.

Authors:  Tiene G M Bauters; Franky M A Buyle; Gerda Verschraegen; Karen Vermis; Dirk Vogelaers; Geert Claeys; Hugo Robays
Journal:  Pharm World Sci       Date:  2007-03-13

3.  Vibrio fluvialis wound infection associated with medicinal leech therapy.

Authors:  M R Varghese; R W Farr; M K Wax; B J Chafin; R M Owens
Journal:  Clin Infect Dis       Date:  1996-04       Impact factor: 9.079

Review 4.  Clinical uses of the medicinal leech: a practical review.

Authors:  B S Porshinsky; S Saha; M D Grossman; P R Beery Ii; S P A Stawicki
Journal:  J Postgrad Med       Date:  2011 Jan-Mar       Impact factor: 1.476

5.  Leech-borne Serratia marcescens infection following complex hand injury.

Authors:  J A Pereira; J R Greig; H Liddy; L Ion; A L Moss
Journal:  Br J Plast Surg       Date:  1998-12

6.  Experiments on the possible role of leeches as vectors of animal and human pathogens: a light and electron microscopy study.

Authors:  M Nehili; C Ilk; H Mehlhorn; K Ruhnau; W Dick; M Njayou
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

7.  Nosocomial Infections with Aeromonas hydrophila from Leeches.

Authors:  Catherine Sartor; Frédérique Limouzin-Perotti; Régis Legré; Dominique Casanova; Marie-Claude Bongrand; Rolland Sambuc; Michel Drancourt
Journal:  Clin Infect Dis       Date:  2002-06-04       Impact factor: 9.079

8.  Elimination of symbiotic Aeromonas spp. from the intestinal tract of the medicinal leech, Hirudo medicinalis, using ciprofloxacin feeding.

Authors:  K Y Mumcuoglu; L Huberman; R Cohen; V Temper; A Adler; R Galun; C Block
Journal:  Clin Microbiol Infect       Date:  2009-06-11       Impact factor: 8.067

Review 9.  Bacterial symbioses of the medicinal leech Hirudo verbana.

Authors:  Michael C Nelson; Joerg Graf
Journal:  Gut Microbes       Date:  2012-05-10

10.  Recommendations for the use of leeches in reconstructive plastic surgery.

Authors:  Kosta Y Mumcuoglu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-06       Impact factor: 2.629

View more
  5 in total

1.  Medical leech therapy in plastic reconstructive surgery.

Authors:  Khosrow S Houschyar; Arash Momeni; Zeshaan N Maan; Malcolm N Pyles; Olivia S Jew; Marion Strathe; Andreas Michalsen
Journal:  Wien Med Wochenschr       Date:  2015-08-22

2.  Curcumin liposomes interfere with quorum sensing system of Aeromonas sobria and in silico analysis.

Authors:  Ting Ding; Tingting Li; Zhi Wang; Jianrong Li
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

3.  Ideating iDNA: Lessons and limitations from leeches in legacy collections.

Authors:  Mark E Siddall; Megan Barkdull; Michael Tessler; Mercer R Brugler; Elizabeth Borda; Evon Hekkala
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 4.  Complications of leech therapy.

Authors:  Matineh Pourrahimi; Mojtaba Abdi; Roshanak Ghods
Journal:  Avicenna J Phytomed       Date:  2020 May-Jun

5.  A Comprehensive Review of Medicinal Leeches in Plastic and Reconstructive Surgery.

Authors:  Paige N Hackenberger; Jeffrey E Janis
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.